Skip to main content

Table 3 Embryo morphokinetic parameters recorded by TLS GERI plus®

From: Human papillomavirus infection in women undergoing in-vitro fertilization: effects on embryo development kinetics and live birth rate

 

Embryos from

HPV-positive women

(n = 202)

Embryos from

HPV-negative

women

(n = 244)

Δ time

p

tPNa (h)

7.97 ± 2.07

7.47 ± 1.89

0.50

0,150

tPNf (h)

23.40 ± 2.64

24.95 ± 5.39

− 1.55

0,005

t2 (h)

27.00 ± 3.75

28.15 ± 4.87

− 1.15

0,051

t3 (h)

36.99 ± 4.90

37.91 ± 10.16

− 0.92

0,389

t4 (h)

39.03 ± 7.82

40.12 ± 9.42

− 1.09

0,369

t8 (h)

62.15 ± 13.08

62.19 ± 14.78

− 0.04

0,986

tSB (h)

102.32 ± 8.72

100.25 ± 9.58

2.07

0,205

tB (h)

122.76 ± 9.04

118.90 ± 10.20

3.86

0,049

tHN (h)

115.55 ± 7.92

113.29 ± 11.41

2.26

0,429

tPNf – tPNa (h)

15.51 ± 2.83

17.40 ± 5.90

− 1.89

0,014

t2 – tPNf (h)

3.58 ± 2.97

3.52 ± 2.26

0.06

0,874

t3 – t2 (h)

10.19 ± 3.98

9.72 ± 8.52

0.47

0,594

t4 – t3 (h)

2.42 ± 4.72

3.08 ± 5.49

− 0.66

0,367

t4 – t2 (h)

12.55 ± 6.65

12.30 ± 7.21

0.25

0,798

t8 – t4 (h)

23.34 ± 11.64

24.13 ± 13.27

− 0.79

0,690

  1. Time and time intervals are shown for 202 embryos of HPV-positive women and 244 embryos of HPV-negative women. The ∆Time column shows the difference between embryos of HR-HPV-positive women and those of negative women for each morphokinetic parameter. Values are expressed as mean ± SD